Article ID Journal Published Year Pages File Type
3933881 Fertility and Sterility 2009 4 Pages PDF
Abstract
The higher cabergoline dose might have prevented an increase in the severity of OHSS and its prolongation following occurrence of pregnancy. Randomized controlled trials assessing the efficacy and safety of different doses and durations of cabergoline administration in both prophylactic and therapeutic settings are required.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
High dose cabergoline in management of ovarian hyperstimulation syndrome
Authors
, , , ,